Streetbeat News

Partnerships

BTBT

NVDA

SMCI

Bit Digital has received an initial batch of servers equipped with Nvidia HGX H100 GPUs from Super Micro Computer. The company expects the remaining 103 servers by the first week of January 2024 and plans to deploy them in Iceland in January 2024. Additionally, Bit Digital has amended its agreement to include a three-month prepayment from its customer.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 1:07 pm

NKLA

Nikola Corporation (NKLA) and FirstElement Fuel (FEF) have entered into a 10-year strategic partnership to advance hydrogen fueling infrastructure. FEF will become an authorized Nikola Fueling Solutions Partner, providing fueling services at a new station in Oakland, California, with a capacity of 200 trucks per day. This station is part of Nikola's strategy to deploy zero-emissions trucks near Maritime Ports in California and is funded by the California Energy Commission. Nikola aims to develop up to 60 stations, including mobile and permanent HYLA branded stations, customer-owned stations, and public truck stops. The partnership aligns with California's carbon emission reduction goals and Nikola's broader strategy to establish a robust hydrogen supply chain and refueling ecosystem.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 1:06 pm

CCI

Crown Castle (CCI) has initiated a comprehensive review of its fiber business and has appointed two new independent directors, Jason Genrich and Sunit Patel, to its board. These actions are part of a cooperation agreement with Elliott Investment Management. The company has also formed new committees to oversee the review of the fiber business and the search for a new CEO.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 1:05 pm

EOLS

Evolus, Inc. (NASDAQ:EOLS) has entered into an exclusive licensing agreement with Symatese to distribute four next-generation dermal fillers in the UK and Europe, with regulatory approvals expected in the second half of 2024 and commercialization in 2025. The agreement expands Evolus' international market and complements the launch of Nuceiva, their flagship neurotoxin. Evolus will issue 610,000 shares to Symatese and make milestone payments upon regulatory approvals. The company expects to be fully funded to profitability by 2025 and will pre-announce Q4 and FY23 results and 2024 revenue guidance in January.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 1:04 pm

MYGN

Myriad Genetics, Inc. has launched the Myriad Collaborative Research Registry (MCRR), formerly known as the Precise Treatment Registry. The MCRR is a comprehensive pan-cancer registry with data from over one million patients, encompassing germline and tumor testing results from Myriad's cancer products. This registry is one of the largest of its kind and is freely available for research to promote clinical data sharing and advance the field of precision medicine.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 1:03 pm

RXRX

Recursion Pharmaceuticals has partnered with Enamine to create screening libraries using Recursion's MatchMaker protein-ligand interaction predictions. These libraries will be designed from Enamine's vast library of 36 billion compounds, focusing on up to 100 biological targets. Enamine will have the option to sell these libraries to customers and will co-brand them under both Enamine and MatchMaker trademarks.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 1:01 pm

MSFT

Bill Gates, co-founder of Microsoft Corp. (NASDAQ:MSFT), expressed optimism about AI's role in healthcare breakthroughs. He highlighted five areas where AI could have a significant impact: combating antibiotic resistance, personalized tutoring, treating high-risk pregnancies, assessing HIV risk, and improving access to medical information. Despite global challenges, Gates believes AI will accelerate research and innovation, particularly in healthcare.

Portfolio Pulse from Rounak Jain

December 20, 2023 | 12:57 pm

EOSE

Eos Energy Enterprises (EOSE) has partnered with Partner4Work to create a $500K training program aimed at upskilling the current and future workforce for Eos' manufacturing facility in the Mon Valley. This initiative is expected to enhance the skill set of employees, aligning with the company's growth and operational efficiency goals.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 12:44 pm

ABSI

Absci Corporation (ABSI) has partnered with PrecisionLife to develop a joint portfolio of AI-enabled drug pipeline projects. The collaboration aims to discover and develop biotherapeutics for up to five targets and indications, focusing on chronic diseases with unmet clinical needs. Both companies will share in the potential value of the programs developed.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 12:33 pm

INKT

MiNK Therapeutics has entered into a collaboration with ImmunoScape to accelerate the identification of novel TCRs and the development of TCR-based therapeutics. This partnership aims to enhance MiNK's pipeline of TCR therapeutics for cancer and other diseases. ImmunoScape's deep immunomics platform will be utilized to identify and analyze TCRs, potentially leading to more effective treatments.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 12:32 pm